Top Line

Eighty percent of Americans receiving vaccination have either already received a COVID-19 booster shot or are planning to get one when it becomes available, a new Morning Consult vote Moderna and Johnson & Johnson suggest before a meeting of federal regulators this week to consider approving the boosters—but most Republicans still plan to hold off on the additional shot.

important facts

- Advertisement -

The survey, conducted October 7–9 among 2,200 US adults, including 1,488 vaccinated, found that 70% of vaccination respondents would get a booster shot “if it is recommended” and 10% said they would get the booster shot before. Just got the shot.

That 10% figure exceeds the Centers for Disease Control and Prevention’s count, which reports Only 4.9% of adults have received a booster shot so far.

Only 7% of vaccinated respondents were unwilling to have a booster shot, while 13% said they were unsure.

Republican respondents overall were less likely to get a booster than those who were not vaccinated, with 36% of those surveyed planning to get the shot, 39% saying they wouldn’t and 19% not sure, while 6% saying that. He already had.

Democrats were much more inclined to get the booster shot: 69% said they would get it and 9% said they already have it, versus 11% who don’t plan to get it and 11% were unsure .

big number

8.5 million. This is the number of Americans who have already received a COVID-19 booster shot, According For the CDC, of ​​the 187.7 million people who have been fully vaccinated.

what to see

An advisory panel for the Food and Drug Administration will meet on Thursday and Friday to consider whether to authorize booster shots of Moderna and Johnson & Johnson’s COVID-19 vaccines. recently FDA review Moderna’s boosters provided to the panel did not take a position on whether additional shots should be recommended, but suggested that the agency consider approving vaccines only for certain groups, as in the Pfizer/BioNTech vaccine. did with.

amazing facts

The CDC reports that 1.5 million people have already received booster shots of Moderna Vaccine, which is authorized only for the immunocompromised. Another 9,085 have received boosters for the Johnson & Johnson vaccine, which is not yet approved for the immunocompromised. NS new York Times notes This number is possible because some people may have found pharmacies willing to give an extra shot even though it has not yet been approved, or people may have asked about their vaccination status to get another dose. may have lied.

main background

COVID-19 booster shots have become a concern in light of the evidence showing the vaccines’ effectiveness over time and that they are less protective against infection by the delta variant. Vaccines are still highly effective in preventing serious illness, hospitalization and death from COVID-19. The White House initially wanted the entire general public to get booster shots starting in September, but that plan was put into motion when federal regulators only approved Pfizer’s vaccine for certain populations, including the elderly, those with underlying conditions. and those at high potential risk of covid. 19. Figures shows Booster shots are now overtaking initial vaccination, however, despite only being approved for certain groups. While the Biden administration has strongly encouraged booster shots, they remain controversial in the global public health community. The World Health Organization and a number of researchers have opposed boosters for the general public, questioning whether shots are necessary at this time, arguing that it is the doses from wealthier countries that are more likely to vaccinate people in low-income countries. will be used better. Vaccination rates are still low amid a limited supply.

Millions of vaccinated adults can now get a booster shot. 10% say they already have (morning consultation)

In review, FDA remains neutral on need for Moderna Booster (new York Times)

COVID-19 booster shots overtake first dose in US (axial)

Johnson & Johnson submits booster shot data to FDA for authorization (Businesshala)

CDC advisors recommend Pfizer boosters for seniors and some people with underlying conditions (Businesshala)